MIM SurePlan™ MRT
Advancing Molecular Radiotherapy
MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for Molecular Radiotherapy.
Practical Dosimetry Achieved
Calculating patient-specific dose doesn’t need to add significant time to your workflow. Effective dosimetry, organ and tumor segmentation, deformable registration, and communication tools that help reduce clinical effort are all available in a single solution — MIM SurePlan MRT.
Advancing Molecular Radiotherapy
MIM SurePlan MRT standardizes the dosimetry process in a single, vendor-neutral solution. Automation is integrated at every step of the process to help Nuclear Medicine departments capture the therapy opportunity, without sacrificing patient care.
Vendor-Neutral Quantitative Corrections
MIM SurePlan MRT includes support for quantitative SPECT reconstruction – ensuring that reconstruction can be performed on your existing cameras. Additionally, having a vendor-neutral platform can help standardize reconstructions across your department.
Time-Saving AI Auto-Segmentation
Leveraging our experience in Radiation Oncology, MIM Software offers several industry-leading segmentation tools to help you save time in the dosimetry process. These include atlas-based segmentation available for normal structures, our new artificial intelligence platform for automatic segmentation of normal structures, and a single-click tool for tumor segmentation.
Single Timepoint Dosimetry
This state-of-the-art dosimetry process allows estimation of the absorbed dose with only a single SPECT/CT, further reducing the requirements needed to perform dosimetry.
Multiple Molecular Radiotherapy tracers, such as Lutathera Lu-177 dotatate, Azedra I-131 iobenguane, Hicon I-131 NAI for thyroid, and more can be imaged with MIM SurePlan MRT, confirming dose delivery in the patient.
Save time and improve accuracy over conventional registration techniques with MIM’s automatic image registration to propagate VOIs between timepoints with minimal or no adjustment.
MIM SurePlan MRT provides vendor-neutral quantitative SPECT reconstruction with SPECTRA Quant® and planar corrections to provide activity concentration measurements for time-activity curve generation and dosimetry calculations.
MIM SurePlan MRT performs voxel-based absorbed dose calculation using the patient's own anatomy. MIM SurePlan MRT calculates dose using the voxel s-value (VSV) schema in MIRD Pamphlet No. 17 and provides dose maps and DVH curves for analysis. Tools for Lu-177 and I-131 FDA approved therapies are available for clinical use and tools for other radionuclide therapies are available for research use.
Integrated Dosimetry Reporting
MIM SurePlan MRT offers an integrated reporting solution that allows for the incorporation of images and statistics into reports to provide more information to referring physicians about the treatment course.
Stephen A. Graves, PhD
Why Dosimetry for Radiopharmaceutical Therapy Matters
Dr. Stephen A. Graves notes that dosimetry for radiopharmaceutical therapy is significant. In addition, he reminds us that the drug is the radiation-absorbed dose and not the radiopharmaceutical itself.